Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 27, 2025 | May 28, 2025 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | June 30, 2025 | July 02, 2025 |
| CVR ENERGY INCCVI · Entity 4008 | Director | August 01, 2025 | August 07, 2025 |
| DANA IncDAN · Entity 6 | Director | May 30, 2025 | June 02, 2025 |
| ICAHN ENTERPRISES L.P.IEP · Entity 3928 | Director | September 30, 2024 | October 02, 2024 |
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | Director | May 01, 2026 | May 04, 2026 |
| NEWELL BRANDS INC.NWL · Entity 4339 | Director | February 16, 2023 | February 21, 2023 |
| SANDRIDGE ENERGY INCSD · Entity 2054 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date May 27, 2025 · Filed May 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 61,147 |
Reported balance
After 2025-05-27 transaction · row 1
1 source rowRow 1 · 2025-05-27 · Grant · Acquired 20,338 · Balance 61,147 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.
Bausch Health Companies Inc.
Report date June 30, 2025 · Filed July 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 220,280 |
Reported balance
After 2025-06-30 transaction · row 1
1 source rowRow 1 · 2025-06-30 · Grant · Acquired 4,034 · Balance 220,280 F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.
CVR ENERGY INC
Report date August 01, 2025 · Filed August 07, 2025
This filing explicitly reported no securities owned.
DANA Inc
Report date May 30, 2025 · Filed June 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 132 |
Reported balance
After 2025-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-30 · Grant · Acquired 61 · Balance 132 F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.
ICAHN ENTERPRISES L.P.
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Depository UnitsSEC Table I · non-derivative | Direct | 345,761 |
Reported balance
After 2024-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-09-30 · Tax withholding · Disposed 34,179 · Balance 345,761 F1: Depositary Units representing limited partner interests in Icahn Enterprises L.P. F2: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024 |
Filing footnotes · ownership attribution and instrument terms
F1: Depositary Units representing limited partner interests in Icahn Enterprises L.P.
F2: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,712 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Exercise / conversion · Acquired 1,712 · Balance 34,712 F1: Represent RSUs granted under the Non-Employee Director Compensation Program. F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Exercise / conversion · Disposed 1,712 · Balance 0 F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F1: Represent RSUs granted under the Non-Employee Director Compensation Program. F3: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represent RSUs granted under the Non-Employee Director Compensation Program.
F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.
F3: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026.
NEWELL BRANDS INC.
Report date February 16, 2023 · Filed February 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 471,003 |
Ending reported balance
After 2023-02-17 transaction · row 3
2 source rows · reconciled sequenceRow 1 · 2023-02-16 · Sale · Disposed 107,372 · Balance 845,631 F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive. Row 3 · 2023-02-17 · Sale · Disposed 374,628 · Balance 471,003 F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectCharitable Foundation | 213,714 |
Reported balance
After 2023-02-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-02-16 · Sale · Disposed 26,286 · Balance 213,714 F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive. |
| Common StockSEC Table I · non-derivative | IndirectCharitable Foundation | 122,000 |
Reported balance
After 2023-02-17 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2023-02-17 · Sale · Disposed 91,714 · Balance 122,000 F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.
F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.
SANDRIDGE ENERGY INC
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,709 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 9,804 · Balance 22,709 F1: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 20:31 UTC | SANDRIDGE ENERGY INC SD · Entity 2054 | GrantCommon Stock | 9,804 | $15.30 | $150,001.20 |
DisclosureSEC source: 0001387184-26-000003 · primarydocument.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,709 F1 · shares: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders. Read SEC document |
| May 01, 2026 Filed May 4, 2026 21:09 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 1,712 | $70.81 | $121,226.72 |
DisclosureSEC source: 0001225208-26-004882 · doc4.xml · derivative · entry 2 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F1 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F3 · derivative.exercise_date: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026. F3 · derivative.expiration_date: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026. Read SEC document |
| May 01, 2026 Filed May 4, 2026 21:09 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 1,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004882 · doc4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F2 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 20:29 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 2,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004736 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,903 Underlying: Common Stock · 2,903 shares Expires 2027-04-29 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The RSUs will vest on the one-year anniversary of the grant date. F3 · derivative.expiration_date: The RSUs will vest on the one-year anniversary of the grant date. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 22:17 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantCommon Stock | 13,000 | $64.44 | $837,749.90 |
DisclosureSEC source: 0001225208-25-009120 · doc4.xml · nonDerivative · entry 2 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 F2 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $63.19 to $65.31 inclusive. The reporting person undertakes to provide to the issuer, any security holder of theissuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 22:17 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantCommon Stock | 20,000 | $62.96 | $1,259,218.00 |
DisclosureSEC source: 0001225208-25-009120 · doc4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.65 to $63.43 inclusive. The reporting person undertakes to provide to the issuer, any security holder of theissuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:21 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008914 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,712 Underlying: Common Stock · 1,712 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.expiration_date: The RSUs will vest on May 1, 2026. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:38 UTC | SANDRIDGE ENERGY INC SD · Entity 2054 | GrantCommon Stock, par value $0.001 per share | 12,905 | $10.00 | $129,050.00 |
DisclosureSEC source: 0001213900-25-072134 · ownership.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,905 F1 · security: Reflects shares of restricted stock granted on August 1, 2025 which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:38 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018673 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,280 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:20 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 61 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005597 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132 Underlying: Common Stock, par value $0.01 · 61 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:04 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015801 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,147 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:38 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 54,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015040 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,246 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,119 | $6.47 | $33,119.93 |
DisclosureSEC source: 0001127602-25-010796 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,899 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| March 21, 2025 Filed Mar 21, 2025 20:53 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003573 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71 Underlying: Common Stock, par value $0.01 · 71 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:25 UTC | DANA Inc DAN · Entity 6 | GrantRestricted Stock Units · Derivative | 10,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001670 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,104 Underlying: Common Stock, par value $0.01 · 10,104 shares Expires not disclosed F1 · security: Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan. F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights. F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant. F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 12:50 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,109 | $8.06 | $33,118.54 |
DisclosureSEC source: 0001127602-25-000001 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,780 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,059 | $8.16 | $33,121.44 |
DisclosureSEC source: 0001127602-24-024688 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,671 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:31 UTC | ICAHN ENTERPRISES L.P. IEP · Entity 3928 | Tax withholdingDepository Units | 34,179 | $13.37 | $456,973.23 |
DisclosureSEC source: 0001062993-24-017300 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,761 F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P. F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024 Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:52 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021755 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,809 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:46 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,752 | $6.97 | $33,121.44 |
DisclosureSEC source: 0001127602-24-019573 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,612 F1 · shares: Reflects Restricted Share Units issued?in?lieu?of?cash?compensation?in?connection with the Reporting Person's service on the Issuer's Board?of?Directors for the quarter ending June 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| May 17, 2024 Filed May 20, 2024 21:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 35,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016023 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,860 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:31 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,122 | $10.61 | $33,124.42 |
DisclosureSEC source: 0001127602-24-011594 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,500 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,130 | $8.02 | $33,122.60 |
DisclosureSEC source: 0001127602-24-000128 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,378 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 21:15 UTC | ICAHN ENTERPRISES L.P. IEP · Entity 3928 | Tax withholdingDepositary Units | 29,206 | $20.15 | $588,448.33 |
DisclosureSEC source: 0001539497-23-001679 · ownership.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,940 F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P. F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2023. F3 · balance_after: Includes 742 Depositary Units previously received by the Reporting Person as a payment-in-kind dividend in a transaction exempt from Section 16(a) and Section 16(b) liability pursuant to Rule 16a-9(a) and Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended, which were inadvertently excluded from the aggregate ownership amount in prior filings. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,029 | $8.22 | $33,118.38 |
DisclosureSEC source: 0001127602-23-025001 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,248 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:39 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008690 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164 Underlying: Common Stock, par value $0.01 · 49 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,140 | $8.00 | $33,120.00 |
DisclosureSEC source: 0001127602-23-020001 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,219 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:40 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006600 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115 Underlying: Common Stock, par value $0.01 · 57 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| May 19, 2023 Filed May 19, 2023 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 29,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016281 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,079 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:24 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014696 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,113 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:03 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,684 | $8.10 | $29,840.40 |
DisclosureSEC source: 0001127602-23-012410 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,874 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 20:36 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004286 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58 Underlying: Common Stock, par value $0.01 · 58 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:14 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 91,714 | $14.95 | $1,371,124.30 |
DisclosureSEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 4 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Charitable Foundation Disclosed balance after: 122,000 F2 · price: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:14 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 374,628 | $14.95 | $5,600,688.60 |
DisclosureSEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 3 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,003 F2 · price: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:42 UTC | DANA Inc DAN · Entity 6 | Exercise / conversionRestricted Stock Units · Derivative | 6,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002410 · doc4.xml · derivative · entry 4 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 · 6,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights. F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant. F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:42 UTC | DANA Inc DAN · Entity 6 | Exercise / conversionDividend Equivalent Rights · Derivative | 159 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002410 · doc4.xml · derivative · entry 3 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 · 159 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:42 UTC | DANA Inc DAN · Entity 6 | Exercise / conversionCommon Stock, par value $0.01 | 159 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002410 · doc4.xml · nonDerivative · entry 2 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:42 UTC | DANA Inc DAN · Entity 6 | Exercise / conversionCommon Stock, par value $0.01 | 6,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002410 · doc4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:14 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 26,286 | $15.37 | $404,015.82 |
DisclosureSEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 2 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Charitable Foundation Disclosed balance after: 213,714 F1 · price: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:14 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 107,372 | $15.37 | $1,650,307.64 |
DisclosureSEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845,631 F1 · price: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:50 UTC | DANA Inc DAN · Entity 6 | GrantRestricted Stock Units · Derivative | 7,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002116 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,982 Underlying: Common Stock, par value $0.01 · 7,982 shares Expires not disclosed F1 · security: Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan. F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights. F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant. F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,589 | $6.28 | $28,818.92 |
DisclosureSEC source: 0001127602-23-000170 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,190 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 21:40 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012314 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159 Underlying: Common Stock, par value $0.01 · 38 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:15 UTC | ICAHN ENTERPRISES L.P. IEP · Entity 3928 | Tax withholdingDepositary Units | 17,920 | $49.77 | $891,878.40 |
DisclosureSEC source: 0001539497-22-001625 · ownership.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,404 F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P. F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2022. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,444 | $6.89 | $30,619.16 |
DisclosureSEC source: 0001127602-22-023263 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,601 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 20:17 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 10,000 | $17.10 | $171,000.00 |
DisclosureSEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 4 ICAHN BRETT · CIK 0001387184 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Charitable Foundation Disclosed balance after: 240,000 F3 · price: The price reported is a weighted average stock price. Shares were sold between $17.00 and $17.18, inclusive. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 20:17 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 71,304 | $16.89 | $1,204,324.56 |
DisclosureSEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 3 ICAHN BRETT · CIK 0001387184 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 953,003 F2 · price: The price reported is a weighted average stock price. Shares were sold between $16.70 and $17.18, inclusive. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 20:17 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 150,000 | $17.51 | $2,626,500.00 |
DisclosureSEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 2 ICAHN BRETT · CIK 0001387184 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Charitable Foundation Disclosed balance after: 250,000 F1 · price: The price reported is a weighted average stock price. Shares were sold between $17.19 and $17.71, inclusive. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 20:17 UTC | NEWELL BRANDS INC. NWL · Entity 4339 | SaleCommon Stock | 150,000 | $17.51 | $2,626,500.00 |
DisclosureSEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,307 F1 · price: The price reported is a weighted average stock price. Shares were sold between $17.19 and $17.71, inclusive. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:45 UTC | DANA Inc DAN · Entity 6 | GrantDividend Equivalent Rights · Derivative | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010139 · doc4.xml · derivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121 Underlying: Common Stock, par value $0.01 · 44 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.